Drugmaker to Seek Approval for World’s First Malaria Vaccine

Your News Companion by Ben Mathis-Lilley
Oct. 8 2013 5:12 PM

Drugmaker to Seek Approval for World’s First Malaria Vaccine

86179461
South Sudanese children are educated on the use of a long-lasting insecticide-treated net.

Photo by TONY KARUMBA/AFP/Getty Images

British drug maker GlaxoSmithKline (GSK) is set to seek regulatory approval for the world’s first malaria vaccine after trials with the drug caused a 50 percent drop in the number of malaria cases in African children.

The vaccine is called RTS,S and was developed by GSK along with the non-profit Path Malaria Vaccine Initiative, with funding from the Bill and Melinda Gates Foundation. The vaccine has been in development by GSK for three decades and the trial was the largest-ever clinical trial conducted in Africa, involving almost 15,500 children across seven countries, the BBC reports.

Advertisement

The nearly 50 percent drop in childhood malaria cases, while dramatic, traditionally wouldn't make a vaccine a sure thing, as most childhood vaccines provide at least 90 percent protection, according to NBC News. The vaccine was also less effective in preventing malaria in infants with only 27 percent effectiveness. But, the sheer scope of the devastating impact of malaria, particularly in the developing world, makes grading on a curve more than acceptable, says GSK. “The sheer number of children affected by malaria means that the number of cases of the disease the vaccine can help prevent is impressive,” Andrew Witty, CEO of GSK, said in the statement. “These data support our decision to submit a regulatory application for the vaccine candidate.”

Malaria afflicts 216 million people each year and kills more than 600,000, where most of the fatalities are children under 5 years old in sub-Saharan Africa, according to the World Health Organization. According to Bloomberg, “GSK plans to submit the vaccine to the European Medicines Agency for approval next year, and the WHO has said it may in 2015 recommend RTS,S for use if safety and efficacy are satisfactory.”

GSK has pledged to keep the cost of the vaccine low, NPR reports, with prices no more than the cost of production plus a 5 percent profit that the company says it will invest in developing other vaccines for neglected diseases.

Elliot Hannon is a writer in Washington, D.C. Follow him on Twitter.

TODAY IN SLATE

Politics

Meet the New Bosses

How the Republicans would run the Senate.

The U.S. Is So, So Far Behind Europe on Clean Energy

The Government Is Giving Millions of Dollars in Electric-Car Subsidies to the Wrong Drivers

The Best Thing About the People’s Climate March in NYC

Friends Was the Last Purely Pleasurable Sitcom

The Eye

This Whimsical Driverless Car Imagines Transportation in 2059

Medical Examiner

Did America Get Fat by Drinking Diet Soda?  

A high-profile study points the finger at artificial sweeteners.

A Woman Who Escaped the Extreme Babymaking Christian Fundamentalism of Quiverfull

John Oliver Debunks the Miss America Pageant’s Claim That It Gives Out $45 Million in Scholarships

Trending News Channel
Sept. 20 2014 11:13 AM Watch Flashes of Lightning Created in a Lab  
  News & Politics
Over There
Sept. 22 2014 1:29 PM “That’s Called Jim Crow” Philip Gourevitch on America’s hypocritical interventions in Africa.
  Business
Moneybox
Sept. 22 2014 1:37 PM Subprime Loans Are Back! And believe it or not, that’s a good thing.
  Life
Lexicon Valley
Sept. 22 2014 1:22 PM Is Arabic Really Just One Language? 
  Double X
The XX Factor
Sept. 22 2014 12:29 PM Escaping the Extreme Christian Fundamentalism of "Quiverfull"
  Slate Plus
Slate Plus
Sept. 22 2014 1:52 PM Tell Us What You Think About Slate Plus Help us improve our new membership program.
  Arts
Television
Sept. 22 2014 2:12 PM Crusader, Sans Cape The superhero trappings of Gotham are just a clever disguise.
  Technology
Future Tense
Sept. 22 2014 12:14 PM Family Court Rules That You Can Serve Someone With Legal Papers Over Facebook
  Health & Science
Science
Sept. 22 2014 12:15 PM The Changing Face of Climate Change Will the leaders of the People’s Climate March now lead the movement?
  Sports
Sports Nut
Sept. 18 2014 11:42 AM Grandmaster Clash One of the most amazing feats in chess history just happened, and no one noticed.